In 2024, MB Bioriba had revenue of 108.7 thousand EUR.
| year | 2024Latest | 2023 | 2022 |
|---|---|---|---|
Revenue | 108,7k € | 0 € | 0 € |
Profit | - | - | - |
Assets | - | - | - |
Liabilities | - | - | - |
Equity | - | - | - |
Employees | - | - | - |
Overall rating | B68/100 |
Financial health | 50/100 |
Credit history | 70/100 |
Legal history | 100/100 |
Business activity | 60/100 |
| Overall risk | Medium |
No risk flags | |
Possible tax debts | |
No financial data available | |
Regular report filing | |
| Description | Registered |
|---|---|
| CEO (Male) |
MB Bioriba is located at Naujoji Akmenė, Statybininkų g. 21, LT-85192, LT-LT-85192.
The shareholders of MB Bioriba include 1 Lithuanian legal entities. View ownership details →
Yes, MB Bioriba is registered as an active VAT payer with VAT number LT100015970215.
MB Bioriba was founded on October 25, 2022. The company has been operating for 4 years.
| Indicator | Value | Rank | Comparison | |
|---|---|---|---|---|
Company age | 4 years | 180 - 184 | 20% | |
Net revenue | 108 677,00 € | 136 - 140 | 39% |
Annual financial report for 2024.
Annual financial report for 2023.
Annual financial report for 2022.
Registered in the Lithuanian register of legal entities.